Contractor
MYLAN PHARMACEUTICALS INC
- UEI
- NDN1MYB8DKK5
- Parent UEI
- TZY5BKQHCF21
- Resolved by
- uei
- Confidence
- 1.000
Active from Nov 25, 2022 to Oct 14, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79723D0025 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Nov 25, 2022 | — |
| 36E79725D0054 3 LINE ITEMS FOR CLONIDINE PATCHES. AWARDED FOR A BASE YEAR OF 11/30/2025 TO 11/29/2026. | Department of Veterans Affairs | — | Aug 21, 2025 | — |
| 36E79723D0015 NEW AWARD FOR CLOZAPINE TABLETS WITH MYLAN. ORDERING PERIOD IS MARCH 4, 2023 TO MARCH 3, 2024 WITH FOUR ONE-YEAR OPTIONS | Department of Veterans Affairs | — | Feb 2, 2023 | — |
| 36E79726D0033 2 LINE ITEMS FOR BUDESONIDE/FORMOTEROL ORAL INHALERS. AWARDED FOR A BASE YEAR OF 8/7/2026 TO 8/6/2027 PLUS 4 ONE-YEAR PERIODS. | Department of Veterans Affairs | — | Jul 24, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier NDN1MYB8DKK5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.